Maravai LifeSciences Holdings is a Stock to Watch in 2023, Recently Closing at $15.77, Up 5.34% from Previous Price.
March 12, 2023
Trending News 🌥️
Maravai ($NASDAQ:MRVI) LifeSciences Holdings Inc. is one of the stocks to watch in 2023. This is an exciting development for investors, as it shows great potential for the company and its stock. The company is well-positioned for continued growth in the coming years and could prove to be a great investment for those who take the time to research it. Now that the stock has closed at $15.77, up 5.34% from its previous price of $14.97, investors should keep a close eye on this company’s progress and performance in the coming months and years.
Market Price
News sentiment from this stock has been mostly positive, making it an attractive option for investors. Despite this recent dip, it still closed the day 5.34% up overall. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Maravai Lifesciences. More…
| Total Revenues | Net Income | Net Margin |
| 883 | 220.21 | 24.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Maravai Lifesciences. More…
| Operations | Investing | Financing |
| 495.38 | 105.66 | -159.05 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Maravai Lifesciences. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.25k | 1.41k | 3.83 |
Key Ratios Snapshot
Some of the financial key ratios for Maravai Lifesciences are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 83.4% | 185.6% | 64.8% |
| FCF Margin | ROE | ROA |
| 54.2% | 71.0% | 15.9% |
Analysis
At GoodWhale, we recently conducted an analysis of MARAVAI LIFESCIENCES‘s wellbeing. Based on our Risk Rating, MARAVAI LIFESCIENCES is determined to be a medium risk investment in terms of both financial and business aspects. We detected 3 risk warnings in the income sheet, balance sheet and cashflow statement. If you’re interested in taking a closer look at these risks and their implications for MARAVAI LIFESCIENCES, you can register with us to get access to more information. At GoodWhale, we strive to provide the best insights and analysis for our customers so that they can make informed decisions when it comes to their investments. More…
Peers
The competition between Maravai LifeSciences Holdings Inc and its competitors is fierce. Takara Bio Inc, Forward Pharma A/S, Obio Technology (shanghai) Corp Ltd are all trying to gain market share in the rapidly growing life sciences market. Maravai LifeSciences Holdings Inc has a strong product portfolio and is well-positioned to compete in this market.
– Takara Bio Inc ($TSE:4974)
Takara Bio Inc. is a Japanese biotechnology company that specializes in the development, manufacturing, and marketing of biotechnology products. The company was founded in 1953 and is headquartered in Kyoto, Japan. Takara Bio has four main business segments: biopharmaceuticals, bio-agriculture, bio-industry, and diagnostics. The company’s products include enzymes, proteins, antibodies, and nucleic acids used in research and development, drug discovery, and diagnostic applications. Takara Bio also offers agricultural products, such as plant growth regulators and soil amendments. In addition, the company provides contract research and development services.
– Forward Pharma A/S ($NASDAQ:FWP)
Write a paragraph on it’s market cap and ROE and a brief intro of what the company does:
Forward Pharma A/S has a market cap of 22.41M as of 2022, a Return on Equity of -3.32%. The Company is focused on developing and commercializing therapies for the treatment of inflammatory diseases.
– Obio Technology (shanghai) Corp Ltd ($SHSE:688238)
Obio Technology (shanghai) Corp Ltd is a publicly traded company with a market cap of 11.59B as of 2022. The company has a return on equity of 2.0%. The company is engaged in the business of providing technology solutions to businesses and consumers. The company’s products and services include software, hardware, and services. The company’s customers include businesses of all sizes, government entities, and individual consumers.
Summary
Maravai LifeSciences Holdings Inc. has been a stock to watch in the market in the past year, due to its recent price closing at $15.77, which is up 5.34% from its previous price. Despite this, news sentiment has been generally positive regarding the stock.
However, it’s important to note that despite this sentiment, the stock price has moved down on the same day. Investors should consider Maravai LifeSciences as a potential investment opportunity as it could potentially prove beneficial in the coming years. Analysts suggest investors should keep an eye on the company’s performance and consider possible future events that could influence the stock. Before investing, investors should do their own research and ensure that Maravai LifeSciences is a good fit for their portfolio.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
